Last Congress, Congressmen Himes and Garrett introduced bipartisan legislation (H.R. 3283) that would provide clarity on this issue.

Section 716 would create significant complications and counter the efforts to resolve [large financial] firms in an orderly manner.

I believe our committee has a real window of opportunity this Congress to meaningfully engage in GSE reform on a bipartisan basis.

I get a lot of different takeaways from this.

the impetus behind Sarbanes-Oxley in the first place was not the small companies, was not the mid-size companies; it was not even these mature mediocrity type companies.

there is really--this is a rhetorical point. While if we can pass legislation and try to do a cost-benefit analysis and say on the one hand is the expense, millions or billions of dollars.

Our written testimony highlights these and suggests how Congress can avoid regulatory duplication without putting State and local governments at risk.

Like Congressman Dold, the MSRB is concerned about the effects of an overly broad definition and the need to avoid regulatory duplication.

But we could also argue that you and your colleagues have been pulling the trigger quite a bit since that time.

Isn't that actually discouraging investment by individuals and businesses at the same time?

Maybe there is a counterfactual to your counterfactual.